Genprex, Inc. Ownership
$2.58
0.86%
Nasdaq, Oct 02, 12:32 pm EDT.
Market open.
Genprex, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Vanguard Fiduciary Trust Co
|
3.550k | 0.70% | +3.550k | Jun 30 2026 |
| 2 |
HRT Financial LP
|
3.275k | 0.64% | +3.275k | Jun 30 2026 |
| 3 |
Geode Capital Management, L.L.C.
|
2.743k | 0.54% | +1.226k | Jun 30 2026 |
| 4 |
Vanguard Capital Management, LLC
|
1.652k | 0.32% | +1.382k | Jun 30 2026 |
| 5 |
Engineers Gate Manager, L.P.
|
949.000 | 0.19% | +949.000 | Jun 30 2026 |
|
1
Vanguard Fiduciary Trust Co
|
0.70%
3.550k
|
|
2
HRT Financial LP
|
0.64%
3.275k
|
|
3
Geode Capital Management, L.L.C.
|
0.54%
2.743k
|
|
4
Vanguard Capital Management, LLC
|
0.32%
1.652k
|
|
5
Engineers Gate Manager, L.P.
|
0.19%
949.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 2.39% of Genprex, Inc., with Vanguard Fiduciary Trust Co the biggest at 0.70%, followed by HRT Financial LP (0.64%) and Geode Capital Management, L.L.C. (0.54%). |
Recent Genprex, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 02 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 29 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 25 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 20 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 14 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 07 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 02 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 29 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 25 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 20 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 14 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 07 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Genprex, Inc. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Genprex, Inc. has held steady at around 10.1% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
